Aadi Bioscience (AADI)
(Real Time Quote from BATS)
$1.80 USD
-0.02 (-1.10%)
Updated Apr 18, 2024 11:52 AM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.66 |
EPS Last Quarter | -0.60 |
Last EPS Surprise | 10.45% |
ABR | 1.40 |
Earnings ESP
|
5.34% |
---|---|
Current Year | -2.47 |
Next Year | -2.91 |
EPS (TTM) | -2.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.41M | 6.85M | 27.80M | 33.89M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 6.73M | 7.00M | 28.56M | 37.30M |
Low Estimate | 6.00M | 6.70M | 27.30M | 30.48M |
Year ago Sales | 5.87M | 6.20M | 24.35M | 27.80M |
Year over Year Growth Est. | 9.20% | 10.42% | 14.15% | 21.91% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.66 | -0.65 | -2.47 | -2.91 |
# of Estimates | 4 | 3 | 5 | 3 |
Most Recent Consensus | -0.62 | -0.65 | -2.66 | NA |
High Estimate | -0.58 | -0.63 | -2.12 | -2.55 |
Low Estimate | -0.71 | -0.68 | -2.73 | -3.20 |
Year ago EPS | -0.57 | -0.67 | -2.44 | -2.47 |
Year over Year Growth Est. | -15.79% | 2.99% | -1.23% | -17.98% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.66 | -0.65 | -2.47 | -2.91 |
7 Days Ago | -0.66 | -0.65 | -2.47 | -2.91 |
30 Days Ago | -0.66 | -0.65 | -2.47 | -2.91 |
60 Days Ago | -0.70 | -0.71 | -2.67 | -3.03 |
90 Days Ago | -0.70 | -0.71 | -2.67 | -3.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.65 | -2.66 | -2.91 |
Zacks Consensus Estimate | -0.66 | -0.65 | -2.47 | -2.91 |
Earnings ESP | 5.34% | 0.51% | -7.87% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.60 | -0.60 | -0.67 | -0.57 | NA |
Estimate | -0.67 | -0.73 | -0.64 | -0.58 | NA |
Difference | 0.07 | 0.13 | -0.03 | 0.01 | 0.05 |
Surprise | 10.45% | 17.81% | -4.69% | 1.72% | 6.32% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more